Fabry Disease Treatment Market - Global Outlook and Forecast 2022-2028

January 2022 | 69 pages | ID: F70308E43B2EEN
Market Monitor Global

Abstracts

Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.

This report contains market size and forecasts of Fabry Disease Treatment in Global, including the following market information:

Global Fabry Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Fabry Disease Treatment market was valued at 1576.6 million in 2021 and is projected to reach US$ 2243.3 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Enzyme Replacement Therapy (ERT) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Fabry Disease Treatment include Sanofi S.A., Takeda, Amicus Therapeutics Inc., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Protalix Biotherapeutics Inc., Idorsia Pharmaceuticals Ltd., Avrobio Inc. and Greenovation Biotech GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fabry Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fabry Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Fabry Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Enzyme Replacement Therapy (ERT)
• Chaperone Treatment
• Substrate Reduction Therapy (SRT)
• Others

Global Fabry Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Fabry Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Fabry Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Fabry Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Fabry Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Fabry Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi S.A.
• Takeda
• Amicus Therapeutics Inc.
• ISU Abxis Co Ltd.
• JCR Pharmaceuticals Co Ltd.
• Protalix Biotherapeutics Inc.
• Idorsia Pharmaceuticals Ltd.
• Avrobio Inc.
• Greenovation Biotech GmbH
• Moderna Therapeutics Inc.
• Green Cross Pharma Pte Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Fabry Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Fabry Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FABRY DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Fabry Disease Treatment Market Size: 2021 VS 2028
2.2 Global Fabry Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Fabry Disease Treatment Players in Global Market
3.2 Top Global Fabry Disease Treatment Companies Ranked by Revenue
3.3 Global Fabry Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Fabry Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Fabry Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fabry Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Fabry Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Fabry Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Fabry Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Enzyme Replacement Therapy (ERT)
  4.1.3 Chaperone Treatment
  4.1.4 Substrate Reduction Therapy (SRT)
  4.1.5 Others
4.2 By Type - Global Fabry Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Fabry Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Fabry Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Fabry Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Fabry Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Fabry Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Fabry Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Fabry Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Fabry Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Fabry Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Fabry Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Fabry Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Fabry Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Fabry Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Fabry Disease Treatment Revenue, 2017-2028
  6.3.2 US Fabry Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Fabry Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Fabry Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Fabry Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Fabry Disease Treatment Market Size, 2017-2028
  6.4.3 France Fabry Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Fabry Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Fabry Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Fabry Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Fabry Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Fabry Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Fabry Disease Treatment Revenue, 2017-2028
  6.5.2 China Fabry Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Fabry Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Fabry Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Fabry Disease Treatment Market Size, 2017-2028
  6.5.6 India Fabry Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Fabry Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Fabry Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Fabry Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Fabry Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Fabry Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Fabry Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Fabry Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Fabry Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi S.A.
  7.1.1 Sanofi S.A. Corporate Summary
  7.1.2 Sanofi S.A. Business Overview
  7.1.3 Sanofi S.A. Fabry Disease Treatment Major Product Offerings
  7.1.4 Sanofi S.A. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 Sanofi S.A. Key News
7.2 Takeda
  7.2.1 Takeda Corporate Summary
  7.2.2 Takeda Business Overview
  7.2.3 Takeda Fabry Disease Treatment Major Product Offerings
  7.2.4 Takeda Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 Takeda Key News
7.3 Amicus Therapeutics Inc.
  7.3.1 Amicus Therapeutics Inc. Corporate Summary
  7.3.2 Amicus Therapeutics Inc. Business Overview
  7.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Major Product Offerings
  7.3.4 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 Amicus Therapeutics Inc. Key News
7.4 ISU Abxis Co Ltd.
  7.4.1 ISU Abxis Co Ltd. Corporate Summary
  7.4.2 ISU Abxis Co Ltd. Business Overview
  7.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Major Product Offerings
  7.4.4 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 ISU Abxis Co Ltd. Key News
7.5 JCR Pharmaceuticals Co Ltd.
  7.5.1 JCR Pharmaceuticals Co Ltd. Corporate Summary
  7.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
  7.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Major Product Offerings
  7.5.4 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 JCR Pharmaceuticals Co Ltd. Key News
7.6 Protalix Biotherapeutics Inc.
  7.6.1 Protalix Biotherapeutics Inc. Corporate Summary
  7.6.2 Protalix Biotherapeutics Inc. Business Overview
  7.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Major Product Offerings
  7.6.4 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Protalix Biotherapeutics Inc. Key News
7.7 Idorsia Pharmaceuticals Ltd.
  7.7.1 Idorsia Pharmaceuticals Ltd. Corporate Summary
  7.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
  7.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Major Product Offerings
  7.7.4 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Idorsia Pharmaceuticals Ltd. Key News
7.8 Avrobio Inc.
  7.8.1 Avrobio Inc. Corporate Summary
  7.8.2 Avrobio Inc. Business Overview
  7.8.3 Avrobio Inc. Fabry Disease Treatment Major Product Offerings
  7.8.4 Avrobio Inc. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.8.5 Avrobio Inc. Key News
7.9 Greenovation Biotech GmbH
  7.9.1 Greenovation Biotech GmbH Corporate Summary
  7.9.2 Greenovation Biotech GmbH Business Overview
  7.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Major Product Offerings
  7.9.4 Greenovation Biotech GmbH Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.9.5 Greenovation Biotech GmbH Key News
7.10 Moderna Therapeutics Inc.
  7.10.1 Moderna Therapeutics Inc. Corporate Summary
  7.10.2 Moderna Therapeutics Inc. Business Overview
  7.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Major Product Offerings
  7.10.4 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.10.5 Moderna Therapeutics Inc. Key News
7.11 Green Cross Pharma Pte Ltd.
  7.11.1 Green Cross Pharma Pte Ltd. Corporate Summary
  7.11.2 Green Cross Pharma Pte Ltd. Business Overview
  7.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Major Product Offerings
  7.11.4 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue in Global Market (2017-2022)
  7.11.5 Green Cross Pharma Pte Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Fabry Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Fabry Disease Treatment Market Drivers in Global Market
Table 3. Fabry Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Fabry Disease Treatment in Global Market
Table 5. Top Fabry Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Fabry Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Fabry Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Fabry Disease Treatment Product Type
Table 9. List of Global Tier 1 Fabry Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fabry Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Fabry Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Fabry Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Fabry Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Fabry Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Fabry Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Fabry Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Fabry Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Fabry Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Fabry Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Fabry Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Fabry Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Fabry Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Fabry Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Fabry Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Fabry Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Fabry Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Fabry Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Fabry Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Fabry Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi S.A. Corporate Summary
Table 31. Sanofi S.A. Fabry Disease Treatment Product Offerings
Table 32. Sanofi S.A. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Takeda Corporate Summary
Table 34. Takeda Fabry Disease Treatment Product Offerings
Table 35. Takeda Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Amicus Therapeutics Inc. Corporate Summary
Table 37. Amicus Therapeutics Inc. Fabry Disease Treatment Product Offerings
Table 38. Amicus Therapeutics Inc. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. ISU Abxis Co Ltd. Corporate Summary
Table 40. ISU Abxis Co Ltd. Fabry Disease Treatment Product Offerings
Table 41. ISU Abxis Co Ltd. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. JCR Pharmaceuticals Co Ltd. Corporate Summary
Table 43. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product Offerings
Table 44. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Protalix Biotherapeutics Inc. Corporate Summary
Table 46. Protalix Biotherapeutics Inc. Fabry Disease Treatment Product Offerings
Table 47. Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Idorsia Pharmaceuticals Ltd. Corporate Summary
Table 49. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product Offerings
Table 50. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Avrobio Inc. Corporate Summary
Table 52. Avrobio Inc. Fabry Disease Treatment Product Offerings
Table 53. Avrobio Inc. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Greenovation Biotech GmbH Corporate Summary
Table 55. Greenovation Biotech GmbH Fabry Disease Treatment Product Offerings
Table 56. Greenovation Biotech GmbH Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Moderna Therapeutics Inc. Corporate Summary
Table 58. Moderna Therapeutics Inc. Fabry Disease Treatment Product Offerings
Table 59. Moderna Therapeutics Inc. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Green Cross Pharma Pte Ltd. Corporate Summary
Table 61. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product Offerings
Table 62. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Fabry Disease Treatment Segment by Type in 2021
Figure 2. Fabry Disease Treatment Segment by Application in 2021
Figure 3. Global Fabry Disease Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Fabry Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Fabry Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fabry Disease Treatment Revenue in 2021
Figure 8. By Type - Global Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Fabry Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Fabry Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi S.A. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Takeda Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amicus Therapeutics Inc. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ISU Abxis Co Ltd. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Avrobio Inc. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Greenovation Biotech GmbH Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Moderna Therapeutics Inc. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)